Type I IFN‐mediated synergistic activation of mouse and human DC subsets by TLR agonists

Publisher： John Wiley & Sons Inc

E-ISSN： 1521-4141|14-2980|10|2798-2809

ISSN： 0014-2980

Source： EUROPEAN JOURNAL OF IMMUNOLOGY, Vol.14-2980, Iss.10, 2015-10, pp. : 2798-2809

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Type I IFN‐mediated synergistic activation of mouse and human DC subsets by TLR agonists

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 10, 2015-10 ,pp. : 2798-2809

John Wiley & Sons Inc

Access to resources Recommend Favorite

TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 4, 2015-04 ,pp. : 1159-1169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of in vitro Costimulation with TLR2, TLR4 and TLR9 Agonists and HIV-1 on Antigen-Presenting Cell Activation

By  

Intervirology, Vol. 58, Iss. 2, 2015-04 ,pp. : 122-129

Karger

Access to resources Recommend Favorite

Hepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptor

By                  

International Journal of Molecular Medicine, Vol. 29, Iss. 4, 2012-01 ,pp. : 581-586

Spandidos Publications

Access to resources Recommend Favorite

Mouse superkiller‐2‐like helicase DDX60 is dispensable for type I IFN induction and immunity to multiple viruses

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 12, 2015-12 ,pp. : 3386-3403

John Wiley & Sons Inc

Access to resources Recommend Favorite